The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.
Apr 11, 2014
0
0
University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.
Mar 27, 2013
0
0
A new study conducted by European researchers in Denmark suggests that regular use of pain relief medications such as aspirin, can lead to a decreased risk of serious ovarian cancer in women. This is important news because ...
Nov 7, 2012
0
0
Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They ...
Sep 27, 2012
0
0
Aspirin use appears to reduce the risk of Barrett's esophagus (BE), the largest known risk factor for esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice ...
Jul 23, 2012
0
0
A new study from American Cancer Society researchers finds use of 30 tablets a month or more of acetaminophen for five or more years was associated with an estimated 38% lower risk of prostate cancer. The study appears in ...
May 23, 2011
0
0
